Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

Clinical trial NCT06493253 · COMPLETED

Trial details

NCT number: NCT06493253
Sponsor: PharmaNest, Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Metabolic Dysfunction-associated Steatotic Liver Disease

Start date: 2025-09-01
Primary completion: 2026-03-15
Enrollment: 1519

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.